perhaps the value lies in the fact that the can safely inject R327 into a patient but they can't inject bleach, to kill these bacteria. As for their inablity to recruit patients... That seems worth noting. Was there any explanation as to why they weren't able to recruit more patients?
Correct me if I'm wrong but I seem to recall seeing a number of photos of healed diabetic ulcers which had not responded to the conventional protocols....was this unrelated or irrelevant? Serious question... always appreciate being better informed.
- Forums
- ASX - By Stock
- RCE
- Ann: R327 Efficacy against WHO Priority Pathogen Acinetobacter B
RCE
recce pharmaceuticals ltd
Add to My Watchlist
3.17%
!
30.5¢

Ann: R327 Efficacy against WHO Priority Pathogen Acinetobacter B, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
30.5¢ |
Change
-0.010(3.17%) |
Mkt cap ! $87.95M |
Open | High | Low | Value | Volume |
31.0¢ | 31.0¢ | 30.0¢ | $25.09K | 82.18K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 32855 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.5¢ | 16280 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 32855 | 0.300 |
6 | 35183 | 0.290 |
2 | 135000 | 0.285 |
8 | 112420 | 0.280 |
2 | 30909 | 0.275 |
Price($) | Vol. | No. |
---|---|---|
0.305 | 16280 | 1 |
0.310 | 93028 | 1 |
0.330 | 25000 | 1 |
0.350 | 10000 | 1 |
0.375 | 8002 | 1 |
Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |